share_log

Earnings Outlook For Champions Oncology

Earnings Outlook For Champions Oncology

冠军肿瘤学的收益展望
Benzinga ·  03/12 02:00

Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Tuesday, 2024-03-12. Here's what investors need to know before the announcement.

Champions Oncology(纳斯达克股票代码:CSBR)定于2024-03-12星期二发布其最新的季度收益报告。以下是投资者在宣布之前需要了解的内容。

Analysts estimate that Champions Oncology will report an earnings per share (EPS) of $-0.15.

分析师估计,Champions Oncology将公布的每股收益(EPS)为-0.15美元。

Champions Oncology bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

Champions Oncology的多头希望听到该公司宣布他们不仅超过了这一预期,而且还为下一季度提供积极的指导或预期的增长。

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

新投资者应注意,有时对股票价格影响最大的不是收益超过或失败,而是指导方针(或预测)。

Historical Earnings Performance

历史收益表现

Last quarter the company beat EPS by $0.02, which was followed by a 5.42% increase in the share price the next day.

上个季度,该公司每股收益高出0.02美元,随后第二天股价上涨了5.42%。

Here's a look at Champions Oncology's past performance and the resulting price change:

以下是Champions Oncology过去的表现以及由此产生的价格变化:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate -0.17 -0.10 -0.12 -0.03
EPS Actual -0.15 -0.16 -0.17 -0.16
Price Change % 5.0% -1.0% 0.0% -2.0%
季度 2024 年第二季度 2024 年第一季度 2023 年第四季度 2023 年第三季度
每股收益估算 -0.17 -0.10 -0.12 -0.03
实际每股收益 -0.15 -0.16 -0.17 -0.16
价格变动% 5.0% -1.0% 0.0% -2.0%

eps graph

Stock Performance

股票表现

Shares of Champions Oncology were trading at $5.7 as of March 08. Over the last 52-week period, shares are up 30.39%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

截至3月8日,Champions Oncology的股票交易价格为5.7美元。在过去的52周中,股价上涨了30.39%。鉴于这些回报率普遍为正数,长期股东应该对本财报感到满意。

To track all earnings releases for Champions Oncology visit their earnings calendar on our site.

要追踪Champions Oncology的所有财报,请访问我们网站上的财报日历。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成,并由编辑审阅。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发